{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:27:15Z","timestamp":1793636835555,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.thromres.2026.109858","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:31:11Z","timestamp":1790836271000},"page":"109858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anticoagulation quality in antiphospholipid syndrome according to INR testing strategy"],"prefix":"10.1016","volume":"266","author":[{"given":"Sara R.","family":"Vazquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer J.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2026.109858_bb0005","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"T","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chest.2024.03.003","article-title":"Antithrombotic therapy for VTE disease: compendium and review of CHEST guidelines 2012\u20132021","volume":"166","author":"Stevens","year":"2024","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.amjmed.2024.09.019","article-title":"Vitamin K antagonist anticoagulation in antiphospholipid syndrome: time in therapeutic range and clinical outcomes","volume":"138","author":"Meir","year":"2025","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.thromres.2026.109858_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4321\/S1886-36552009000400004","article-title":"Evaluation of patient perceptions and outcomes related to anticoagulation point-of-care testing in ambulatory care clinics","volume":"7","author":"Thompson","year":"2009","journal-title":"Pharm Pract (Granada)"},{"issue":"3","key":"10.1016\/j.thromres.2026.109858_bb0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.thromres.2004.05.013","article-title":"Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial","volume":"114","author":"Woods","year":"2004","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2026.109858_bb0030","first-page":"386","article-title":"Patients' satisfaction associated with portable coagulometers for warfarin monitoring: a cross-sectional study","volume":"18","author":"Riva","year":"2020","journal-title":"Blood Transfus."},{"issue":"8","key":"10.1016\/j.thromres.2026.109858_bb0035","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/phar.1616","article-title":"Patient specific factors influencing adherence to INR monitoring","volume":"35","author":"Kauffman","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2026.109858_bb0040","series-title":"CADTH Optimal Use Reports","article-title":"Point-of-care testing of international normalized ratio for patients on oral anticoagulant therapy: systematic review and economic analysis","year":"2014"},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0045","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1309\/P2Y3VM4AXPVUDAW3","article-title":"Clinical impact of point-of-care vs laboratory measurement of anticoagulation","volume":"123","author":"Sunderji","year":"2005","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.thromres.2026.109858_bb0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.thromres.2008.10.006","article-title":"Accuracy and clinical usefulness of the CoaguChek S and XS point of care devices when starting warfarin in a hospital outreach setting","volume":"123","author":"Sobieraj-Teague","year":"2009","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2026.109858_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s12288-022-01611-4","article-title":"Comparison of point-of-care PT-INR by hand-held device with conventional PT-INR testing in anti-phospholipid antibody syndrome patients on oral anticoagulation","volume":"39","author":"Ganapati","year":"2023","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"5","key":"10.1016\/j.thromres.2026.109858_bb0060","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/ijlh.12523","article-title":"Evaluation of a new PT-INR monitoring system in patients with the antiphospholipid syndrome","volume":"38","author":"Braham","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109858_bb0065","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/j.thromres.2012.01.011","article-title":"Antiphospholipid syndrome patients: the performance of Coagucheck XS in the monitoring of vitamin K-antagonists","volume":"129","author":"Barcellona","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2026.109858_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100011","article-title":"Interference in point-of-care international normalized ratio monitoring in patients with lupus anticoagulant is correlated with anti-\u03b22-glycoprotein I antibody titers","volume":"7","author":"Noordermeer","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109858_bb0075","article-title":"Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies","volume":"94","author":"P","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109858_bb0080","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/1060028014546361","article-title":"Warfarin monitoring in antiphospholipid syndrome and lupus anticoagulant","volume":"48","author":"Crowl","year":"2014","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.thromres.2026.109858_bb0085","article-title":"Monitoring warfarin therapy in patients with lupus anticoagulants","volume":"127","author":"M","year":"1997","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2026.109858_bb0090","first-page":"10","article-title":"Potential failure of the International Normalized Ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants","volume":"147","author":"Della Valle","year":"1996","journal-title":"Ann. Med. Interne (Paris)"},{"issue":"3","key":"10.1016\/j.thromres.2026.109858_bb0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1046\/j.1365-2141.2001.03178.x","article-title":"Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins","volume":"115","author":"Tripodi","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2026.109858_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1591029","article-title":"Impact of thromboplastin reagents on monitoring INR in a patient with triple-positive antiphospholipid syndrome: a case report","volume":"16","author":"Varju","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.thromres.2026.109858_bb0105","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/jth.13481","article-title":"Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH","volume":"14","author":"Tripodi","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109858_bb0110","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jth.15217","article-title":"Monitoring of anticoagulation in thrombotic antiphospholipid syndrome","volume":"19","author":"Cohen","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109858_bb0115","series-title":"CoaguChek XS Plus system. Roche Diagnostics","year":"2022"},{"key":"10.1016\/j.thromres.2026.109858_bb0120","series-title":"Coag-Sense Prothrombin Time (PT)\/INR Monitoring System Patient Self-Testing User Manual. Coag-Sense","year":"2023"},{"key":"10.1016\/j.thromres.2026.109858_bb0125","series-title":"microINR System. iLine Microsystems","year":"2020"},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0130","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109858_bb0135","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"7","key":"10.1016\/j.thromres.2026.109858_bb0140","article-title":"Comparison of two point-of-care international normalized ratio devices and laboratory method","volume":"28","author":"V","year":"2017","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"1","key":"10.1016\/j.thromres.2026.109858_bb0145","article-title":"Correction factor to improve agreement between point-of-care and laboratory international normalized ratio values","volume":"74","author":"J","year":"2017","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"4","key":"10.1016\/j.thromres.2026.109858_bb0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2026.109858_bb0155","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109858_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.thromres.2019.07.021","article-title":"Accuracy of ICD-10 codes for identifying hospitalizations for acute anticoagulation therapy-related bleeding events","volume":"181","author":"Joos","year":"2019","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2026.109858_bb0165","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/pds.4783","article-title":"Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries","volume":"28","author":"Shehab","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0170","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11239-019-01885-y","article-title":"Assessing the accuracy of ICD-10 codes for identifying acute thromboembolic events among patients receiving anticoagulation therapy","volume":"48","author":"Lawrence","year":"2019","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.thromres.2026.109858_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2023.100154","article-title":"Accuracy of venous thromboembolism ICD-10 codes: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2024","journal-title":"Thrombosis Update"},{"issue":"2","key":"10.1016\/j.thromres.2026.109858_bb0180","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.thromres.2026.109858_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"issue":"SI","key":"10.1016\/j.thromres.2026.109858_bb0190","doi-asserted-by":"crossref","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","article-title":"Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations","volume":"63","author":"Gaspar","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.thromres.2026.109858_bb0195","doi-asserted-by":"crossref","DOI":"10.1177\/02683555251413935","article-title":"Prevalence, incidence proportion and independent predictors of thromboembolic events in adults with antiphospholipid syndrome: A systematic review with meta-analysis","author":"Essouma","year":"2026","journal-title":"Phlebology: The Journal of Venous Disease"},{"key":"10.1016\/j.thromres.2026.109858_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2015.10.105","article-title":"Antiphospholipid syndrome and anticoagulation quality: a clinical challenge","volume":"244","author":"Pastori","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.thromres.2026.109858_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/jha2.522","article-title":"Point of care testing to monitor INR control in patients with antiphospholipid syndrome","volume":"3","author":"Masucci","year":"2022","journal-title":"EJHaem"},{"issue":"1","key":"10.1016\/j.thromres.2026.109858_bb0210","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/hematology.2024000547","article-title":"Warfarin and heparin monitoring in antiphospholipid syndrome","volume":"2024","author":"Mittal","year":"2024","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004938482600277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:45:26Z","timestamp":1793634326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004938482600277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S004938482600277X"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109858","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation quality in antiphospholipid syndrome according to INR testing strategy","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109858"}}